Picture of Johnson & Johnson logo

JNJ Johnson & Johnson Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Johnson & Johnson, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

2019
December 29th
2021
January 3rd
2022
January 2nd
2023
December 31st
2023
January 1st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line15,11914,71420,87835,15317,941
Depreciation
Deferred Taxes
Non-Cash Items-101421,459-18,1611,957
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital3,8652,690-4,2382,507-4,011
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities23,41623,53623,41022,79121,194
Capital Expenditures-3,498-3,347-3,652-4,543-4,009
Purchase of Fixed Assets
Other Investing Cash Flow Items-2,696-17,478-5,0315,421-8,362
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-6,194-20,825-8,683878-12,371
Financing Cash Flow Items575-627395-1,60265
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-18,015-6,120-14,047-15,825-8,871
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-802-3,3205027,732-360